Talazoparib 0.25 mg Capsules is an oral prescription medication used in targeted therapy for certain types of cancers associated with BRCA gene mutations. It belongs to a class of medicines known as PARP (Poly ADP-Ribose Polymerase) inhibitors, which work by preventing cancer cells from repairing damaged DNA, helping slow or stop tumor growth.
Talazoparib helps selectively target cancer cells while minimizing damage to normal cells, making it an important treatment option prescribed by healthcare professionals as part of personalized therapy plans. The capsule formulation allows convenient oral administration and supports patient adherence during treatment.
Manufactured under strict pharmaceutical quality standards, Talazoparib 0.25 mg Capsules ensure consistent potency, safety, and reliability for clinical use.
Key Features
-
Contains Talazoparib 0.25 mg active ingredient
-
PARP inhibitor targeted therapy
-
Oral capsule for convenient daily dosing
-
Designed for precision oncology treatment plans
-
Manufactured following international quality standards
Indications
-
BRCA-mutated cancers (as prescribed by a healthcare professional)
-
Targeted anticancer therapy under medical supervision
Dosage & Administration
Take Talazoparib Capsules exactly as prescribed by a qualified healthcare provider. Capsules should be swallowed whole with water and should not be crushed or opened.
Storage Instructions
-
Store below 25°C in a dry place
-
Protect from moisture and direct sunlight
-
Keep out of reach of children
Important Note
Talazoparib 0.25 mg Capsules are prescription medicines and must be used only under medical supervision.
Medical Disclaimer
The information provided about the medicine is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment recommendation. This medication should be used strictly under the guidance of a qualified healthcare professional.
